Intended for EU healthcare professionals only. The information on this website is not country-specific. This is an international disease awareness campaign.
Back
Infographic

Many real-world axSpA patients do not achieve high treatment targets

ASDAS and BASDAI are commonly used in clinical practice.1,2 However, recent studies demonstrate that a high proportion of real-world patients do not achieve ASDAS <2.1 with current treatments.3–5 Explore more below:

Download

Published on

15 Nov 2023
Download

Get similar content directly to your inbox.

Never miss an insight. Register your interest and we'll let you know when new articles are published on this topic

ASDAS: Ankylosing Spondylitis Disease Activity Score; axSpA: axial spondyloarthritis; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index.

1. Mease P et al. Arthritis Rheumatol. 2021;73(suppl 10). 2. Kwon OC and Park M-C. Rheumatology (Oxford). 2022;61:2369–74. 3. Brandt-Juergens J et al. Arthritis Rheumatol. 2022;74(suppl 9). Abstract 0418. 4. Flouri ID et al. Clin Exp Rheumatol. 2022:48. Presentation P45. 5. Ramonda R et al. Ther Adv Musculoskelet Dis. 2022;14:1–18.